Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Bluebird Bio, Inc. (BLUE)  
$0.98 0.01 (1.31%) as of 4:30 Wed 5/22


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 139,126,000
Market Cap: 136.84(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.8871 - $4.83
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   bluebird bio is a company focused on the pursuit of curative gene therapies for severe genetic diseases. Co. has late-stage clinical and research programs for the treatment of sickle cell disease (SCD), ss-thalassemia and cerebral adrenoleukodystrophy and is developing research to apply new technologies to these and other diseases. Using a proprietary lentiviral vector platform, Co. custom designs each of its therapies to address the underlying cause of disease by introducing a functional copy of a gene to patients' own isolated hematopoietic stem cells. Co. is developing lovotibeglogene autotemcel as a one-time treatment for patients with SCD.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 17,438 35,533 57,514 116,582
Total Sell Value $26,639 $61,294 $139,194 $443,003
Total People Sold 3 5 5 9
Total Sell Transactions 3 9 12 23
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 939
  Page 29 of 38  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sullivan Eric Principal Accounting Officer   •       –      –    2015-08-03 4 OE $20.70 $9,237 D/D 416 3,634     -
   Gillis Steven Director   –       •      –    2015-07-28 4 A $0.00 $0 D/D 5,126 18,633     -
   Gillis Steven Director   –       •      –    2015-07-28 4 D $0.00 $0 I/I (233,000) 90,675     -
   Sullivan Eric Principal Accounting Officer   •       –      –    2015-07-20 4 AS $162.24 $110,869 D/D (682) 3,090     -
   Sullivan Eric Principal Accounting Officer   •       –      –    2015-07-17 4 AS $164.58 $73,075 D/D (444) 3,772     -
   Davidson David Chief Medical Officer   •       –      –    2015-07-15 4 AS $165.55 $331,927 D/D (2,000) 0     -
   Davidson David Chief Medical Officer   •       –      –    2015-07-15 4 OE $2.09 $4,180 D/D 2,000 2,000     -
   Walsh Jeffrey T. Chief Operating Officer   •       –      –    2015-07-10 4 AS $157.40 $1,744,942 D/D (11,000) 0     -
   Walsh Jeffrey T. Chief Operating Officer   •       –      –    2015-07-10 4 OE $2.09 $22,990 D/D 11,000 11,000     -
   Cole Jason SVP, Secy. & General Counsel   •       –      –    2015-07-09 4 AS $156.86 $790,963 D/D (5,000) 0     -
   Cole Jason SVP, Secy. & General Counsel   •       –      –    2015-07-09 4 OE $22.53 $112,650 D/D 5,000 5,000     -
   Sullivan Eric Principal Accounting Officer   •       –      –    2015-07-02 4 AS $163.47 $68,003 D/D (416) 4,216     -
   Sullivan Eric Principal Accounting Officer   •       –      –    2015-07-02 4 OE $20.70 $9,237 D/D 416 4,632     -
   Gillis Steven Director   –       •      –    2015-06-25 4 A $0.00 $0 D/D 11,837 13,507     -
   Gillis Steven Director   –       •      –    2015-06-25 4 D $0.00 $0 I/I (538,076) 323,675     -
   Gregory Philip D Chief Scientific Officer   •       –      –    2015-06-15 4 A $0.00 $0 D/D 25,000 25,000     -
   Davidson David Chief Medical Officer   •       –      –    2015-06-15 4 AS $182.45 $366,673 D/D (2,000) 0     -
   Davidson David Chief Medical Officer   •       –      –    2015-06-15 4 OE $2.09 $4,180 D/D 2,000 2,000     -
   Walsh Jeffrey T. Chief Operating Officer   •       –      –    2015-06-10 4 AS $178.61 $1,976,721 D/D (11,000) 0     -
   Walsh Jeffrey T. Chief Operating Officer   •       –      –    2015-06-10 4 OE $2.09 $22,990 D/D 11,000 11,000     -
   Cole Jason SVP, Secy. & General Counsel   •       –      –    2015-06-09 4 AS $184.62 $372,176 D/D (2,000) 0     -
   Cole Jason SVP, Secy. & General Counsel   •       –      –    2015-06-09 4 OE $22.53 $45,060 D/D 2,000 2,000     -
   Sullivan Eric Principal Accounting Officer   •       –      –    2015-06-02 4 AS $190.20 $79,122 D/D (416) 316     -
   Sullivan Eric Principal Accounting Officer   •       –      –    2015-06-02 4 OE $20.70 $9,237 D/D 416 732     -
   Finer Mitchell H. Chief Scientific Officer   •       –      –    2015-06-01 4 AS $188.59 $2,853,800 D/D (15,000) 0     -
  939 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 29 of 38
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us